Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Exocrine pancreatic insufficiency as a possible predictor of pancreatic cancer development.
Authors
James Gore
Department of Internal Medicine, Ochsner Health, New Orleans, LA
James Gore , Karina G. Romo , James Peeples , Abdullah A. Noor , Gabriel I. Uwaifo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 679)
DOI
10.1200/JCO.2024.42.3_suppl.679
Abstract #
679
Poster Bd #
M8
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for hepatobiliary and pancreatic cancer patients who were to receive chemotherapy including cisplatin by the CINV study group of Japan.
First Author: Junji Furuse
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of chemotherapy for patients with unresectable pancreatic cancer concomitant with collagen disease: A multicenter retrospective observational study.
First Author: Hiroyuki Asama
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and the course of hepatobiliary and pancreatic malignant tumors with high microsatellite instability after pembrolizumab administration: A multicenter observational study.
First Author: Yuta Maruki
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Assessing disparities in pancreatic cancer outcomes in African Americans.
First Author: Shiva Shrotriya